This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Example content
Adverse event reporting can be found at the bottom of the page
Prescribing information can be found at the bottom of the page.
Join us on 24 September 2026 to hear from Dr Rebecca Walker, GPwER in Headache, Migraine & Menopause and Dr Jane Davis, GPwER in Women's Health discussing 'Navigating Migraine Care in Women: A Practical Toolkit for Clinicians' followed by a live interactive Q&A.
This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and will include reference to medicines promoted by Pfizer.
Prescribing information can be found at the bottom of the page.
Join us on 24 September 2026 to hear from Dr Rebecca Walker, GPwER in Headache, Migraine & Menopause and Dr Jane Davis, GPwER in Women's Health discussing 'Navigating Migraine Care in Women: A Practical Toolkit for Clinicians' followed by a live interactive Q&A.
This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and will include reference to medicines promoted by Pfizer.
Dr Rebecca Walker is a Devon based GP with specialist roles in Headache Medicine and Menopause Care.
She is a senior member of the teams at the National Migraine Centre and the Exeter Headache Clinic, and an associate in menopause care at Myla Health.
She is the founder of Headaches & Hormones, which provides support and specialist migraine therapies for women struggling with migraine in the menopause transition.
Rebecca is an honorary advisor to the British Association for the Study of Headache.
Dr Walker is a member of the Royal College of General Practitioners, she is a member of the British Menopause Society, the British Association for the study of headache and the British Society for Lifestyle Medicine.
No Biography Available.
Vydura®▼(rimegepant)
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2026 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-13971. December 2025